Want to see SE:EXPRS2 full AI Analyst Report?
ExpreS2ion Biotech Holding AB (EXPRS2) Ratios
ExpreS2ion Biotech Holding AB Ratios
SE:EXPRS2's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, SE:EXPRS2's free cash flow was increased by $12.51M and operating cash flow was $-12.51M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.04 | 2.48 | 6.03 | 4.20 | 19.63 |
| Quick Ratio | 2.04 | 2.48 | 6.03 | 4.20 | 19.63 |
| Cash Ratio | 1.68 | 2.13 | 5.06 | 3.53 | 4.97 |
| Solvency Ratio | -1.24 | -0.86 | -6.74 | -3.45 | -3.63 |
| Operating Cash Flow Ratio | -1.45 | -0.89 | -8.86 | -3.17 | -6.12 |
| Short-Term Operating Cash Flow Coverage | -81.64 | -94.24 | -366.86 | -56.50 | -23.80 |
| Net Current Asset Value | $ 28.11M | $ 54.87M | $ 55.34M | $ 97.91M | $ 134.85M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.06 | 0.03 | 0.03 | 0.02 | 0.02 |
| Debt-to-Capital Ratio | 0.06 | 0.03 | 0.03 | 0.02 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.82 | 1.61 | 1.20 | 1.33 | 1.08 |
| Debt Service Coverage Ratio | -47.54 | -51.35 | -120.99 | -44.24 | -22.31 |
| Interest Coverage Ratio | -117.12 | -93.12 | -211.51 | -146.51 | 0.00 |
| Debt to Market Cap | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.93 | 1.49 | 1.92 | 2.89 | 2.62 |
| Net Debt to EBITDA | 0.88 | 1.24 | 0.55 | 0.88 | 0.75 |
| Profitability Margins | |||||
| Gross Profit Margin | -1171.48% | -88.55% | 48.27% | 0.10% | 38.59% |
| EBIT Margin | -1444.35% | -2246.76% | -1475.94% | -2471.69% | -393.88% |
| EBITDA Margin | -1404.24% | -2135.41% | -1453.23% | -2447.78% | -379.09% |
| Operating Profit Margin | -1444.35% | -2246.76% | -1503.05% | -2508.97% | -395.59% |
| Pretax Profit Margin | -1208.07% | -1479.02% | -1417.97% | -2488.81% | -388.39% |
| Net Profit Margin | -1041.43% | -1196.08% | -1296.47% | -2331.99% | -359.04% |
| Continuous Operations Profit Margin | -1041.43% | -1196.08% | -1296.47% | -2331.99% | -359.04% |
| Net Income Per EBT | 86.21% | 80.87% | 91.43% | 93.70% | 92.44% |
| EBT Per EBIT | 83.64% | 65.83% | 94.34% | 99.20% | 98.18% |
| Return on Assets (ROA) | -58.50% | -34.48% | -116.15% | -86.34% | -28.91% |
| Return on Equity (ROE) | -106.72% | -55.62% | -139.83% | -114.79% | -31.30% |
| Return on Capital Employed (ROCE) | -143.34% | -102.13% | -157.43% | -120.45% | -33.49% |
| Return on Invested Capital (ROIC) | -121.91% | -82.14% | -143.35% | -111.02% | -30.56% |
| Return on Tangible Assets | -59.88% | -35.17% | -119.92% | -88.24% | -29.52% |
| Earnings Yield | -84.20% | -103.46% | -93.87% | -19.01% | -3.80% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.37 | 0.60 | 3.00 | 0.47 | 1.72 |
| Payables Turnover | 11.50 | 0.67 | 1.99 | 0.42 | 4.46 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 7.86 | 1.96 | 3.99 | 5.59 | 10.12 |
| Asset Turnover | 0.06 | 0.03 | 0.09 | 0.04 | 0.08 |
| Working Capital Turnover Ratio | 0.09 | 0.05 | 0.09 | 0.04 | 0.10 |
| Cash Conversion Cycle | 963.75 | 68.92 | -62.08 | -98.32 | 130.12 |
| Days of Sales Outstanding | 995.49 | 612.86 | 121.77 | 774.64 | 211.98 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 31.74 | 543.93 | 183.85 | 872.95 | 81.86 |
| Operating Cycle | 995.49 | 612.86 | 121.77 | 774.64 | 211.98 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -14.38 | -20.06 | -87.45 | -105.58 | -56.62 |
| Free Cash Flow Per Share | -14.38 | -20.58 | -89.19 | -105.99 | -57.50 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -39.00 | -50.07 | -260.09 | -63.84 |
| Capital Expenditure Coverage Ratio | 0.00 | -39.00 | -50.07 | -260.09 | -63.84 |
| Operating Cash Flow Coverage Ratio | -18.53 | -18.88 | -58.96 | -53.82 | -21.64 |
| Operating Cash Flow to Sales Ratio | -11.19 | -11.26 | -14.31 | -19.59 | -3.73 |
| Free Cash Flow Yield | -90.44% | -99.90% | -105.68% | -16.03% | -4.01% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.19 | -0.97 | -1.07 | -5.26 | -26.31 |
| Price-to-Sales (P/S) Ratio | 12.37 | 11.56 | 13.81 | 122.65 | 94.48 |
| Price-to-Book (P/B) Ratio | 1.27 | 0.54 | 1.49 | 6.04 | 8.24 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.11 | -1.00 | -0.95 | -6.24 | -24.93 |
| Price-to-Operating Cash Flow Ratio | -1.11 | -1.03 | -0.97 | -6.26 | -25.32 |
| Price-to-Earnings Growth (PEG) Ratio | 0.03 | 0.01 | 0.03 | -0.04 | 1.46 |
| Enterprise Value Multiple | 0.00 | 0.70 | -0.40 | -4.13 | -24.17 |
| Enterprise Value | -117.79K | -44.91M | 41.49M | 514.70M | 1.12B |
| EV to EBITDA | 0.00 | 0.70 | -0.40 | -4.13 | -24.17 |
| EV to Sales | -0.03 | -14.91 | 5.88 | 101.20 | 91.62 |
| EV to Free Cash Flow | 0.00 | 1.29 | -0.40 | -5.15 | -24.18 |
| EV to Operating Cash Flow | 0.00 | 1.32 | -0.41 | -5.17 | -24.55 |
| Tangible Book Value Per Share | 12.02 | 36.87 | 54.51 | 106.39 | 170.18 |
| Shareholders’ Equity Per Share | 12.54 | 38.32 | 56.66 | 109.52 | 174.08 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.14 | 0.19 | 0.09 | 0.06 | 0.08 |
| Revenue Per Share | 1.29 | 1.78 | 6.11 | 5.39 | 15.17 |
| Net Income Per Share | -13.39 | -21.31 | -79.22 | -125.71 | -54.48 |
| Tax Burden | 0.86 | 0.81 | 0.91 | 0.94 | 0.92 |
| Interest Burden | 0.84 | 0.66 | 0.96 | 1.01 | 0.99 |
| Research & Development to Revenue | 2.73 | 8.85 | 7.29 | 14.02 | 0.80 |
| SG&A to Revenue | 0.00 | 13.79 | 0.00 | 0.00 | 0.29 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.07 | 0.50 | 1.10 | 0.78 | 0.94 |
Currency in SEK